Vanguard Fiduciary Trust
TMCI icon

Vanguard Fiduciary Trust’s Treace Medical Concepts TMCI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
292,504
-25,500
-8% -$70.1K ﹤0.01% 2965
2026
Q1 		$426K Buy
+318,004
New +$634K ﹤0.01% 3262

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Fiduciary Trust's TMCI Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Treace Medical Concepts (TMCI) stake by 8% in Q2 2026, selling an estimated $70.1K and leaving 292,504 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2965.

Vanguard Fiduciary Trust first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Vanguard Fiduciary Trust held 292,504 shares of Treace Medical Concepts worth $1.16M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 25,500 Treace Medical Concepts shares in Q2 2026, an estimated $70.1K.
  • Treace Medical Concepts made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2965 holding.
  • Vanguard Fiduciary Trust first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.